Tuesday, the FDA said it received reports of patients developing T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment...
Twenty-seven percent of workers prioritize wellbeing support over salary increase CHICAGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TELUS Health today released its monthly TELUS Mental...
Gracell is pioneering use of a CD19/BCMA dual-targeted CAR-T cell therapy in refractory systemic lupus erythematosus, aiming for deeper and wider depletion of disease-causing...
New York, USA, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Peripheral T-Cell Lymphoma Market to Observe Growth at a CAGR of 4.9% in the US by 2032 | DelveInsight The rapid growth in the...
Institutional investors have a significant influence over TELUS (TSX:TIXT) Corporation, with a collective ownership of 54%, spearheaded by RBC (TSX:RY) Dominion Securities Inc.,...
Phase 1 trial to investigate multiple B-cell mediated autoimmune diseases First healthy donor-derived allogeneic CAR T cell therapy to announce IND clearance Expect to disclose...
In spite of a 2.4% fall in the S&P/TSX Composite High Dividend Index, certain high-yield stocks are presenting investment opportunities. Whitecap Resources (OTC:SPGYF), an energy...
VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- TELUS Health today unveiled its latest innovation, a next-generation Medical Alert Pendant - a discreet wearable...